Novel aspects of antiplatelet therapy in cardiovascular disease

Antiplatelet therapy is a cornerstone in the secondary prophylaxis of adverse cardiovascular events such as myocardial infarction and stroke. The cyclooxygenase inhibitor aspirin remains the most frequently prescribed antiplatelet drug, followed by adenosine diphosphate P2Y(12) receptor blockers. Gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gremmel, Thomas, Michelson, Alan D., Frelinger, Andrew L., Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046593/
https://www.ncbi.nlm.nih.gov/pubmed/30046748
http://dx.doi.org/10.1002/rth2.12115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046593/
https://www.ncbi.nlm.nih.gov/pubmed/30046748
http://dx.doi.org/10.1002/rth2.12115

Ejemplares similares